The KLF1 gene, also known as the Krüppel-like factor 1 gene, plays a crucial role in erythroid cell development and the regulation of several blood group antigens, including the Lutheran blood group system. Mutations or variations in this gene can lead to alterations in blood group antigen expression, which may have implications for blood transfusion compatibility and certain hematological conditions.
The KLF1 Gene Lutheran Inhibitor Blood Group Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect variations in the KLF1 gene that influence the expression of the Lutheran blood group antigens. This test is particularly important for individuals who may require blood transfusions or those experiencing unexplained hemolytic anemia, as it helps in identifying potential incompatibilities and guiding appropriate blood transfusion strategies.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw, and analyzing the specific regions of the KLF1 gene relevant to the Lutheran blood group system. The results of this test can provide valuable information for medical professionals in managing and treating patients, ensuring they receive the most compatible blood products and reducing the risk of transfusion-related complications. DNA Labs UAE offers this advanced genetic testing service with a focus on accuracy, reliability, and confidentiality, catering to the specific needs of patients and healthcare providers in the United Arab Emirates.
The ITK Gene Lymphoproliferative Syndrome Type 1 Genetic Test is a specialized diagnostic assessment offered at DNA Labs UAE, designed to identify mutations in the ITK gene, which can lead to Lymphoproliferative Syndrome Type 1. This condition is a rare immune system disorder characterized by an abnormal increase in white blood cells, leading to an increased risk of developing lymphoma, autoimmune disorders, and other immune system-related issues. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic abnormalities in the ITK gene, enabling healthcare providers to make accurate diagnoses, assess risk factors, and tailor personalized treatment plans for affected individuals. Given the complexity and the critical nature of the condition, this genetic test plays a vital role in early detection and management of the syndrome, offering hope and targeted care to patients and their families.
The CTLA4 Gene Lymphoproliferative Syndrome Autoimmune Type 5 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CTLA4 gene. These mutations are associated with a form of lymphoproliferative syndrome, a rare immune system disorder characterized by an overproduction of lymphocytes leading to autoimmune phenomena. This condition can result in various clinical manifestations, including susceptibility to infections, autoimmune diseases, and potentially, malignancies.
This genetic test is crucial for individuals who present symptoms suggestive of the syndrome or have a family history of similar immune disorders. Early and accurate diagnosis through this test can guide appropriate management strategies, including targeted therapies that can significantly improve the quality of life for affected individuals.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the CTLA4 gene. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and adherence to high standards of accuracy and reliability, patients can expect a comprehensive service. The cost encompasses the full testing process, from sample collection to detailed analysis and reporting, ensuring that patients and healthcare providers receive critical genetic information for informed decision-making regarding treatment and management of the condition.
The SH2D1A gene lymphoproliferative syndrome X-linked type 1 genetic test is a specialized diagnostic procedure aimed at detecting mutations in the SH2D1A gene, which are indicative of X-linked lymphoproliferative syndrome type 1 (XLP1). XLP1 is a rare genetic disorder that primarily affects the immune system, leading to an increased vulnerability to Epstein-Barr virus (EBV) infections, lymphoma, and other immune-related issues. Individuals with mutations in the SH2D1A gene have a dysfunctional immune response, which can result in severe and often life-threatening reactions to EBV.
The genetic test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic mutations in the SH2D1A gene. This test is crucial for the early diagnosis of XLP1, enabling appropriate management and treatment strategies to be implemented, potentially improving the prognosis for affected individuals.
This particular test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the SH2D1A gene lymphoproliferative syndrome X-linked type 1 genetic test at DNA Labs UAE is 4400 AED. Opting for this test at DNA Labs UAE ensures that individuals receive accurate and reliable results, thanks to the lab's state-of-the-art technology and expertise in genetic diagnostics. Early detection through this test can be a pivotal step in managing the health and well-being of individuals at risk for or suspected of having XLP1.
The XIAP Gene Lymphoproliferative Syndrome X-Linked Type 2 Genetic Test is a sophisticated diagnostic tool designed to identify mutations in the XIAP gene, which are associated with X-Linked Lymphoproliferative Syndrome Type 2 (XLP2). This condition is a rare genetic disorder that primarily affects the immune system, leading to an increased risk of developing hemophagocytic lymphohistiocytosis (HLH), inflammatory bowel disease, and recurrent infections. Males are predominantly affected due to the X-linked pattern of inheritance.
The test involves analyzing the patient's DNA to detect any abnormalities or mutations in the XIAP gene that could indicate the presence of XLP2. Early detection through this genetic testing is crucial as it enables timely intervention and management of the condition, potentially improving the patient's quality of life and reducing the risk of severe complications.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and reliability in results. The cost of the XIAP Gene Lymphoproliferative Syndrome X-Linked Type 2 Genetic Test is set at 4400 AED, reflecting the intricate technology and expertise involved in conducting this specialized analysis. This test is a vital resource for families with a history of XLP2, offering them a chance for early diagnosis and the possibility of targeted treatment plans for affected family members.
The "AMN Gene Megaloblastic Anemia Type 1 Genetic Test" is a specialized diagnostic tool used to detect mutations in the AMN gene, which are associated with Megaloblastic Anemia Type 1, a rare inherited disorder. This condition is characterized by a deficiency in the absorption of vitamin B12 due to the impaired function of the AMN gene, leading to megaloblastic anemia and a range of neurological symptoms. Early and accurate diagnosis through this genetic test enables targeted treatment approaches, potentially improving patient outcomes.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test provides a comprehensive analysis of the AMN gene for mutations. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with this condition. By choosing this test, patients and healthcare providers can take an important step towards understanding and managing Megaloblastic Anemia Type 1 more effectively.
The "CUBN Gene Megaloblastic Anemia Type 1 Finnish Type Genetic Test" is a specialized diagnostic tool designed to identify mutations in the CUBN gene, which are responsible for a rare form of megaloblastic anemia, primarily observed in the Finnish population. This condition, known as Imerslund-Gräsbeck syndrome, leads to a deficiency in the absorption of vitamin B12, causing symptoms such as fatigue, weakness, and neurological issues due to ineffective red blood cell production.
The test involves analyzing the patient's DNA to detect specific mutations in the CUBN gene that are indicative of this condition. It is a crucial step in diagnosing the disorder, allowing for appropriate management and treatment strategies to be implemented, which may include vitamin B12 supplementation.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results. This genetic test is particularly recommended for individuals of Finnish descent or those with a family history of megaloblastic anemia, as early detection can significantly improve the quality of life for affected individuals.
The CYB5R3 gene methemoglobinemia type 1 genetic test is a specialized diagnostic examination aimed at identifying mutations in the CYB5R3 gene, which are responsible for causing methemoglobinemia type 1. Methemoglobinemia is a rare blood disorder characterized by an increased level of methemoglobin in the blood, leading to symptoms such as cyanosis, fatigue, and in severe cases, neurological complications. Type 1 methemoglobinemia, also known as the erythrocyte type, is inherited in an autosomal recessive pattern and primarily affects the red blood cells' ability to release oxygen to tissues.
The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic mutations in the CYB5R3 gene. Identifying these mutations can confirm a diagnosis of methemoglobinemia type 1, guide treatment decisions, and help assess the risk of passing the condition on to future generations.
Conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test is priced at 4400 AED. DNA Labs UAE is known for its state-of-the-art facilities and adherence to international standards in genetic diagnostics, ensuring accurate and reliable test results. This test is crucial for individuals with a family history of methemoglobinemia or those exhibiting symptoms of the disorder, as early detection and management can significantly improve the quality of life.
The "PDGFRB Gene Myeloproliferative Disorder Chronic with Eosinophilia Genetic Test" is a specialized diagnostic tool used to identify genetic mutations in the PDGFRB gene, which are associated with chronic myeloproliferative disorders accompanied by eosinophilia. This test is critical for individuals exhibiting symptoms or having a family history of such disorders, as it aids in the precise diagnosis, prognosis, and determination of appropriate treatment strategies. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise involved in detecting these specific genetic abnormalities. This test is a vital resource for healthcare providers and patients in managing and understanding the genetic basis of this complex group of disorders.
The ELANE Gene Neutropenia Severe Congenital Type 1 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the ELANE gene, which are responsible for causing Severe Congenital Neutropenia (SCN) Type 1. This condition is characterized by a marked decrease in the number of neutrophils, a type of white blood cell crucial for fighting infections, leading to increased vulnerability to bacterial infections from a young age.
The test is pivotal for individuals with a clinical presentation suggestive of SCN or for those with a family history of the condition, aiming to provide a definitive genetic diagnosis. Early detection through this genetic testing enables appropriate management and treatment strategies to be implemented, potentially improving the quality of life and prognosis for affected individuals.
Priced at 4400 AED, the test encompasses a comprehensive analysis of the ELANE gene to pinpoint mutations that cause the disorder. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test adheres to stringent quality and accuracy standards, ensuring reliable results for patients and healthcare providers.
